Pioneers in the development of bacterial spores as heat stable mucosal vaccines. Oral and sub-lingual delivery.

Expertise in Bacillus probiotics. Development and licensing of novel Bacillus carotenoid rich strains.

Development of Bacillus spores for directed targeting of cancerous cells with anti-tumour drugs

Strain constructions, genetic engineering of Bacillus, QPS and GRAS safety assessments, and more